Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCIR.L Regulatory News (CIR)

  • There is currently no data for CIR

Director/PDMR Shareholding

18 Sep 2015 18:18

RNS Number : 5875Z
Circassia Pharmaceuticals Plc
18 September 2015
 



18 September 2015

Circassia Pharmaceuticals plc

 

Director Dealing

 

Circassia Pharmaceuticals plc ("Circassia" or "the Company") hereby provides notification that it was informed today that Charles Swingland, 63, a Non-Executive Director of the Company, sold the following shares as detailed below:

Class of share

Number of shares sold

Average price

Date on which shares were sold

Ordinary shares of 0.08 pence each

1,230,000

318.24p

16 September 2015

Ordinary shares of 0.08 pence each

9,000

318.72p

17 September 2015

Ordinary shares of 0.08 pence each

754,548

320.24p

18 September 2015

 

Following the above transactions, Charles Swingland retains 65.16 per cent. of his holding prior to these transactions, and now holds 3,728,129 Ordinary Shares representing 1.31 per cent. of the Company's total voting rights.

 

-Ends-

 

For further information, please contact:

Circassia Pharmaceuticals plc

Julien Cotta, Company Secretary

+44 (0) 1865 405560

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBRGDCSBBBGUI
Date   Source Headline
31st Jan 20184:03 pmRNSTotal Voting Rights
17th Jan 20182:42 pmRNSBlock Listing Six Monthly Return
17th Jan 20182:37 pmRNSNotification of Major Holdings
8th Jan 20187:00 amRNSTR-1: Notification of major holdings
5th Jan 20185:31 pmRNSHolding(s) in Company
29th Dec 20177:00 amRNSTotal Voting Rights
19th Dec 20175:48 pmRNSNotification of Major Holdings
4th Dec 20177:00 amRNSTudorza® Meets Primary Endpoints in ASCENT Study
30th Nov 20172:53 pmRNSTotal Voting Rights
29th Nov 20177:00 amRNSCircassia Welcomes New NICEAsthma Guidelines
31st Oct 20175:18 pmRNSTotal Voting Rights Update
16th Oct 201711:39 amRNSNotification of Major Holdings
29th Sep 201712:13 pmRNSTotal Voting Rights Update
27th Sep 20177:00 amRNSInterim results six months ended 30 June 2017
18th Sep 20172:52 pmRNSNotification of Major Holdings
18th Sep 20172:19 pmRNSNotification of Major Holdings
12th Sep 20177:00 amRNSEuropean Launch of NIOX VERO® Nasal Mode
7th Sep 20177:00 amRNSPrimary Endpoints Met in AMPLIFY Phase III Study
1st Sep 20175:21 pmRNSNotification of Major Holdings
31st Aug 201712:52 pmRNSTotal Voting Rights
24th Aug 20174:06 pmRNSNotice of Interim Results
31st Jul 20177:00 amRNSTotal Voting Rights Update
21st Jul 20178:52 amRNSNotification of Major Holdings
17th Jul 20176:28 pmRNSDirector/PDMR Shareholding
14th Jul 201712:29 pmRNSNotification of Major Holdings
30th Jun 20177:00 amRNSBlock Listing Six Monthly Return
30th Jun 20177:00 amRNSTotal Voting Rights Update
29th Jun 20176:08 pmRNSNotification of Major Interest in Shares
27th Jun 201711:48 amRNSNotification of Major Interest in Shares
26th Jun 20174:27 pmRNSNotification of Major Interest in Shares
15th Jun 20175:40 pmRNSNotification of Major Interest in Shares
5th Jun 20175:36 pmRNSDirector/PDMR Shareholding
31st May 201710:59 amRNSTotal Voting Rights Update
31st May 20177:00 amRNSBlock Listing Application
26th May 201711:35 amRNSResult of AGM 2017
26th May 20177:00 amRNSHolding(s) in Company
28th Apr 20175:20 pmRNSAnnual Report and Notice of Annual General Meeting
28th Apr 20173:15 pmRNSTotal Voting Rights Update
25th Apr 20177:02 amRNSNon-Executive Director Retirements
25th Apr 20177:00 amRNSPreliminary Results for Year Ended 31 Dec 2016
18th Apr 20176:09 pmRNSHolding(s) in Company
18th Apr 20174:51 pmRNSNotification of Major Interest in Shares
18th Apr 201710:20 amRNSNotification of Major Interest in Shares
18th Apr 20177:00 amRNSTop-Line Results of House Dust Mite Allergy Study
13th Apr 20176:02 pmRNSHolding(s) in Company
13th Apr 20175:57 pmRNSHolding(s) in Company
12th Apr 20175:34 pmRNSNotification of Major Interest in Shares
12th Apr 20179:00 amRNSNotice of Results
12th Apr 20178:30 amRNSCompletion of Transaction and Admission to Trading
11th Apr 20179:00 amRNSEarly Termination of HSR Waiting Period Granted

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.